Nektar Therapeutics
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NKTR Company Description
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
NKTR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NKTR Smart Score
Score Breakdown
NKTR Company Description
Show More
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NKTR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NKTR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on NKTR's company Twitter account
WallStreetBets
Number of mentions of NKTR in WallStreetBets Daily Discussion
NKTR News
Recent insights relating to NKTR
CNBC Recommendations
Recent picks made for NKTR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NKTR
Corporate Flights
Flights by private jets registered to NKTR
Our Analysis